LivaNova PLC

NASDAQ:LIVN

Medical - Devices

Healthcare
$94.54 +0.96%

+$0.76 today

Market cap
$5.21B
Beta
0.88
P/E (TTM)
40.5
EPS (TTM)
$1.96
52W Low $41.02High $80.96

Volume 1.32M

Average 0.79M

LIVN Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

LivaNova PLCNASDAQ: LIVN

Weighted Avg Shares (Diluted) · Q3 FY2026 · quarter ended Sep 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q3 FY2026 weighted avg shares (diluted) of 57.4M shares rose 4.0% year over year, ahead of the +2.3% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 2.0% from the prior quarter. Over 3 fiscal years it compounded at +0.6% a year.

Context

  • Weighted avg shares (diluted) increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +4.0% holds above the trailing-twelve-month pace of +2.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
57.4M+2.0% QoQ
Last fiscal yearDec 2025
54.5M-0.1% YoY
LTMSep 2026
56.03M+2.3% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.0%——
1 year-0.1%——
3-year CAGR+0.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
54.5M USD
Year-over-year change
-0.1%
4-year CAGR
+1.9%

Weighted Avg Shares (Diluted) vs competitors

How LIVN compares with its peers on the latest reported figures

  • LIVN's LTM Sep 2026 weighted avg shares (diluted) of 56.03M shares is the 6th highest of the 10 companies compared; the peer median is 67.96M shares.
  • Its year-over-year change of +2.3% is the 4th highest of 10, against a peer median of +0.0%.
  • Over three fiscal years its annual growth of +0.6% compares with a peer median of +1.3%.
LIVN Competitors Peer median
Weighted Avg Shares (Diluted) for LIVN and competitors
Company Period LTM YoY 3-year CAGR
BSXBoston Scientific CorporationLTM Jun 20261.49B +0.1%+1.3%
MDTMedtronic plcLTM Jul 20261.29B +0.0%-1.1%
EWEdwards Lifesciences CorporationLTM Jun 2026581.45M -1.6%-2.1%
RMDResMed Inc.LTM Jun 2026146.52M -0.6%-0.6%
STIMNeuronetics, Inc.LTM Mar 202667.96M +71.5%+34.8%
LIVNLivaNova PLCLTM Sep 202656.03M +2.3%+0.6%
HAEHaemonetics CorporationLTM Jun 202646.64M -6.6%-2.7%
NPCENeuroPace, Inc.LTM Mar 202633.11M +10.6%+10.0%
INSPInspire Medical Systems, Inc.LTM Jun 202629.11M -3.9%+2.0%
CVRXCVRx, Inc.LTM Mar 202626.2M +12.8%+8.3%
MOBIMobia Medical, Inc. Common Stock—— ——
Peer median (excluding LIVN) 67.96M+0.0%+1.3%

Competitors are the stored peer set for LIVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.04B1.02B1.15B1.25B1.39B
Cost of Revenue329.37M314.58M382.3M382.56M448.2M
Gross Profit705.99M707.23M771.25M870.87M939.9M
Gross Margin68.2%69.2%66.9%69.5%67.7%
Research & Development183.41M155.81M193.82M182.51M185.8M
Selling, General & Admin471.9M469.24M518.13M526.27M548.8M
Operating Expenses706.78M783.98M839.75M741.82M740.5M
Depreciation & Amortization67.99M57.8M60.86M51.14M42M
EBITDA(6.33M)30.9M38.48M202.52M(129.5M)
EBITDA Margin-0.6%3.0%3.3%16.2%-9.3%
Operating Income(784K)(76.75M)(68.5M)129.05M199.4M
Operating Margin-0.1%-7.5%-5.9%10.3%14.4%
Interest Income435K4.7M22.01M30.08M18.98M
Interest Expense50.15M48.25M58.85M63.07M49.29M
Other Income / Expenses(123.84M)1.56M(12.83M)(40.74M)(420.2M)
Income Before Tax(124.62M)(75.2M)(81.33M)88.31M(220.8M)
Pre-Tax Margin-12.0%-7.4%-7.1%7.0%-15.9%
Income Tax Expense11.2M11.05M(98.88M)25.06M21.6M
Net Income(135.82M)(86.25M)17.55M63.23M(242.5M)
Net Margin-13.1%-8.4%1.5%5.0%-17.5%
EPS (Basic)(2.68)(1.61)0.331.17(4.45)
EPS (Diluted)(2.68)(1.61)0.321.16(4.45)
Weighted Avg Shares50.63M53.5M53.9M54.24M54.5M
Weighted Avg Shares (Diluted)50.63M53.5M54.21M54.57M54.5M

LivaNova PLC

NASDAQ:LIVN

Intrinsic Alpha fair value

Locked

Current Price

$94.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.